Automating Psychiatry Prior Authorizations for Magellan Healthcare

For clinics managing psychiatry Magellan Healthcare prior authorizations, Klivira delivers automation designed for efficiency. Accelerate approvals for critical mental health services and medications.

Revenue cycle directors and prior authorization coordinators face unique challenges in behavioral health, particularly with specialized payers like Magellan Healthcare, a Centene company. The intricate documentation requirements for psychiatric admissions, specialty medications, and advanced therapies demand a robust and precise approach. Klivira's platform is engineered to address these specific operational complexities, reducing manual effort and improving authorization success rates.

The Nuances of Psychiatry PA with Magellan Healthcare

Magellan Healthcare, a Centene company, manages utilization for a broad spectrum of behavioral health services, from inpatient admissions to specialty pharmacy. Their review processes often involve specific clinical criteria like ASAM and InterQual/MCG Behavioral. Navigating these requirements demands a deep understanding of both clinical guidelines and payer-specific policies, which Klivira's platform is designed to provide.

Key Prior Authorization Triggers for Magellan Psychiatry

Inpatient psychiatric and SUD admissions (including concurrent reviews)
Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs
Residential treatment for SUD and eating disorders
Specialty psychiatric medications (e.g., long-acting injectables, esketamine/Spravato, brexanolone/Zulresso, zuranolone/Zurzuvae)
Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy (ECT)
Specialty drugs for tardive dyskinesia (e.g., valbenazine/Ingrezza, deutetrabenazine/Austedo)

EMR Integration and Payer Touchpoints for Magellan Behavioral Health

Klivira integrates directly with major EMR systems to pull relevant clinical data for Magellan Healthcare submissions. This includes DSM-5-TR diagnoses, severity scales (PHQ-9, GAD-7), and medication trial history. Submissions to Magellan typically occur via X12 278, their proprietary provider portal, or ePA channels, all managed through Klivira's unified platform.

Essential Documentation for Magellan Psychiatry Authorizations

DSM-5-TR diagnosis and severity documentation (PHQ-9, GAD-7, Beck scales)
Safety risk assessment (suicidal/homicidal ideation, plan, intent)
Prior level-of-care trials for intensive services
ASAM dimension documentation for SUD admissions
Documented failed antidepressant trials for TMS, per payer specifics
REMS documentation for restricted drugs like esketamine

Mitigating Common Denials in Magellan Psychiatry Workflows

Common denial reasons for Magellan Healthcare psychiatry services include ASAM level mismatches, insufficient step therapy documentation for TMS or specialty injectables, and concurrent review denials for continued stays. Klivira's integrated logic flags these issues pre-submission, guiding users to provide necessary documentation to avoid delays and appeals.

Klivira's Strategic Advantage for Psychiatry PA with Magellan

Klivira's platform is specifically engineered for the complexities of behavioral health prior authorizations. We incorporate ASAM-criteria-aware logic for level-of-care determinations, facilitate concurrent review workflows for inpatient and residential stays, and automate documentation for step-therapy requirements like those for TMS. Our system also flags potential MHPAEA parity issues for review with your compliance team.

Frequently asked questions

What specific types of psychiatry services require prior authorization from Magellan Healthcare?

Magellan Healthcare typically requires prior authorization for inpatient psychiatric and substance use disorder (SUD) admissions, partial hospitalization (PHP), intensive outpatient (IOP), and residential treatments. Additionally, specialty psychiatric medications such as long-acting injectables, esketamine, and advanced therapies like TMS and ECT often require pre-approval.

How does Klivira handle ASAM criteria for SUD admissions with Magellan?

Klivira's platform incorporates ASAM-criteria-aware logic to guide documentation for SUD admissions. This ensures that all six ASAM dimensions are properly addressed and aligned with Magellan's utilization management requirements, reducing the likelihood of level-of-care mismatch denials.

Can Klivira help with prior authorizations for specialty psychiatric medications like esketamine or long-acting injectables?

Yes, Klivira automates the prior authorization process for specialty psychiatric medications, including those with REMS requirements like esketamine (Spravato) and long-acting injectable antipsychotics. The platform ensures that all necessary documentation, such as diagnosis confirmation and prior oral medication trials, is submitted accurately to Magellan Healthcare.

What are common reasons for denials from Magellan Healthcare for psychiatry services, and how does Klivira address them?

Common denials include ASAM level mismatches, insufficient step-therapy documentation for treatments like TMS, and concurrent review denials for continued inpatient stays. Klivira addresses these by providing pre-submission alerts for missing documentation and guiding users to meet Magellan's specific clinical criteria, thereby minimizing denials.

Does Klivira integrate with our EMR to streamline data submission to Magellan Healthcare?

Yes, Klivira integrates with major EMR systems to automatically extract relevant clinical data for prior authorization submissions to Magellan Healthcare. This includes diagnostic codes, severity scales, and treatment history, reducing manual data entry and improving accuracy for submissions via X12 278 or payer portals.